With the end of the SAG-AFTRA strike, Sony's Venom 3 has a new release date.

Spread MCU News

Sony has changed Venom 3’s release date. On Wednesday night, Sony formally said that Venom 3 will now be released in the autumn rather than the summer following the news that the SAG-AFTRA strike had ended. The threequel, which was once scheduled to be in theatres on July 12, 2024, will instead open on November 8, 2024, according to sources. Tom Hardy, who plays the title role in the next movie, will be joined by Chiwetel Ejiofor and Juno Temple, who are newbies to the franchise. Kelly Marcel, who co-wrote the screenplay with Hardy, serves as the film’s director. Although Marcel has written the scripts for the previous three Venom films, this will be her first time behind the camera for the series. Although there are presently no details on the movie, a recent story said that Ejiofor will play Orwell Taylor, one of Eddie Brock’s greatest comic book adversaries. Though Sony has not officially confirmed the actor’s part, there are rumours that the movie’s working title is “Orwell,” which would give those allegations some validity.

Now that the SAG-AFTRA strike has ended, Sony is anticipated to resume Venom 3 production as soon as feasible. The movie was being filmed in Spain for around 30 days prior to Hollywood’s July closure due to the strike. It is anticipated that production would likely get back up this week or in the near future. The movie is one of many high-priority releases that the studios want to pick back up shortly, including Warner Bros.’ Beetlejuice 2 and Marvel Studios’ Deadpool 3. When the first Venom movie came out in 2018, Sony found great success with it. Despite receiving mixed reviews from critics and viewers—the movie has a 30% rating on Rotten Tomatoes—it has made $856 million globally. International theatres accounted for $642.5 million of the film’s massive box office gain. Venom: Let There Be Carnage, the sequel, opened in 2021 but, like many films after Covid, struggled at the box office, taking in just $506.8 million worldwide. Even while the sequel may not have performed as well at the box office as its predecessor, it was nonetheless somewhat successful, earning a fifty-seven percent rating on Rotten Tomatoes.